Cerapedics announces commercial launch of i-FACTOR®+ Matrix in Canada for surgeries
WESTMINSTER -- Cerapedics announced the full commercial availability of i-FACTOR+ MATRIX for surgical implantation in Canada. "We are excited to announce that i-FACTOR+ Matrix is now fully... Read More
Friday November 6, 2020 0 comments
Cerapedics announces Canadian OK of its next-generation bone graft
WESTMINSTER -- Cerapedics, a private ortho-biologics company, today announced Health Canada approval of the company's next-generation bone graft called i-FACTOR+ Matrix, making it the first market... Read More
Tuesday September 15, 2020 0 comments
Cerapedics: FDA approves company's IDE supplement
WESTMINSTER -- Cerapedics announced the U.S. Food and Drug Administration (FDA) has approved the company's Investigational Device Exemption (IDE) supplement, reducing the enrollment requirement for... Read More
Friday July 24, 2020 0 comments
Cerapedics announces FDA approval of PMA supplement based on two-year clinical data
WESTMINSTER -- Cerapedics, a private ortho-biologics company, announced the U.S. Food and Drug Administration (FDA) has approved the company's Premarket Approval (PMA) supplement for i-FACTOR... Read More
Tuesday November 19, 2019 0 comments
Cerapedics to expand Colorado HQ, more than double workforce
WESTMINSTER -- Cerapedics , a private ortho-biologics company, announced the expansion of the company's headquarters in theDenvermetropolitan area. Over the past 18 months, Cerapedics has... Read More
Tuesday July 9, 2019 0 comments
Cerapedics appoints Patrick O’Connor VP of clinical and market development
WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, today announced the appointment of Patrick O'Connor as VP of Clinical and Market Development. "We are pleased to welcome... Read More
Tuesday June 25, 2019 0 comments
Cerapedics announces first patients enrolled in IDE clinical trial of P-15L Bone Graft for TLIF surgery
WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, today announced the first patients have been enrolled in an investigational device exemption (IDE) clinical trial evaluating... Read More
Tuesday July 31, 2018 0 comments
Cerapedics announces closing of $22M financing round led by KCK Group
WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, announced the company completed a $22 million financing led by KCK Group, a family investment fund that focuses on innovative... Read More
Monday July 16, 2018 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
